Edition:
United Kingdom

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

6.53USD
8:36pm GMT
Change (% chg)

$0.13 (+2.03%)
Prev Close
$6.40
Open
$6.45
Day's High
$6.63
Day's Low
$6.45
Volume
8,734
Avg. Vol
20,846
52-wk High
$13.87
52-wk Low
$6.36

Chart for

About

Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of immuno-oncology therapies. The Company is developing drugs and antibodies that block crucial immune checkpoints and reprogram immune T-cells. The Company has a pipeline of four immuno-onc... (more)

Overall

Beta: --
Market Cap(Mil.): $348.98
Shares Outstanding(Mil.): 20.93
Dividend: --
Yield (%): --

Financials

  CRVS.OQ Industry Sector
P/E (TTM): -- 83.62 33.60
EPS (TTM): -2.58 -- --
ROI: -40.42 -0.65 15.05
ROE: -40.82 0.07 16.62

Earnings vs. Estimates